1
|
Sheikh NA, Desai TR, Tirgar PR. Investigation into Iron Chelating and Antioxidant Potential of Melilotus officinalis in Iron Dextran Induced Iron Overloaded Sprague Dawley Rat Model. Drug Res (Stuttg) 2016; 66:618-627. [PMID: 27626608 DOI: 10.1055/s-0042-113182] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
Excess of iron leads to generates free radicals, causes organ damage. Melilotus officinalis (Fabaceae) reported to have various pharmacological activities. It contains flavonoids and phenolic compounds which have iron chelating and antioxidant property. Hence, present study was designed to investigate the beneficial effects of different fractions of M. officinalis for the management of iron overload disease and its complications. Iron overload was induced by 6 IP injections of iron dextran (12.5 mg/100 g) uniformly distributed over the period of 30 days. The different fractions of M. officinalis were given orally and Deferoxamine (DFO) subcutaneously for 30 days. The iron chelating and various biochemical parameters were estimated on 15th and 30th day. The different fractions of M. officinalis demonstrated dose dependant in-vitro iron chelating ability. There were significant (P<0.01) iron chelating potential shows in rats treated with methanolic fraction of methanolic extract (MFME) and methanolic fraction of aqueous extract (MFAE) of M. officinalis as compared to disease control (DC) rats. The rats treated with MFME and MFAE of M. officinalis shows significant (P<0.01) antioxidant and vital organ protective effect as compared to DC rats. Better iron chelation was observed on 30th day and at higher dose (300 mg/kg) as compared to 15th day and at lower dose (150 mg/kg). The present study concludes that MFME and MFAE of M. officinalis have reversible iron chelating and antioxidant potential in rats. The study also proves the possible mechanism of action, as an iron chelator by increasing the excretion of iron in urine and feces.
Collapse
Affiliation(s)
- N A Sheikh
- Department of Pharmacology, Smt. C. V. Gajera Pharmacy Mahila College, Amreli, Gujarat, India
| | - T R Desai
- Department of Pharmacology, School of Pharmacy, RK University, Rajkot, Gujarat, India
| | - P R Tirgar
- Department of Pharmacology, School of Pharmacy, RK University, Rajkot, Gujarat, India
| |
Collapse
|
2
|
|
3
|
Huntley JM, Tarvaz T, Mantle MD, Sederman AJ, Gladden LF, Sheikh NA, Wildman RD. Nuclear magnetic resonance measurements of velocity distributions in an ultrasonically vibrated granular bed. Philos Trans A Math Phys Eng Sci 2014; 372:20130185. [PMID: 24711488 PMCID: PMC3982650 DOI: 10.1098/rsta.2013.0185] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
We report the results of nuclear magnetic resonance imaging experiments on granular beds of mustard grains fluidized by vertical vibration at ultrasonic frequencies. The variation of both granular temperature and packing fraction with height was measured within the three-dimensional cell for a range of vibration frequencies, amplitudes and numbers of grains. Small increases in vibration frequency were found--contrary to the predictions of classical 'hard-sphere' expressions for the energy flux through a vibrating boundary--to result in dramatic reductions in granular temperature. Numerical simulations of the grain-wall interactions, using experimentally determined Hertzian contact stiffness coefficients, showed that energy flux drops significantly as the vibration period approaches the grain-wall contact time. The experiments thus demonstrate the need for new models for 'soft-sphere' boundary conditions at ultrasonic frequencies.
Collapse
Affiliation(s)
- J. M. Huntley
- Wolfson School of Mechanical and Manufacturing Engineering, Loughborough University, Loughborough LE11 3TU, UK
| | - T. Tarvaz
- Wolfson School of Mechanical and Manufacturing Engineering, Loughborough University, Loughborough LE11 3TU, UK
| | - M. D. Mantle
- Department of Chemical Engineering, University of Cambridge, Pembroke Street, Cambridge CB2 3RA, UK
| | - A. J. Sederman
- Department of Chemical Engineering, University of Cambridge, Pembroke Street, Cambridge CB2 3RA, UK
| | - L. F. Gladden
- Department of Chemical Engineering, University of Cambridge, Pembroke Street, Cambridge CB2 3RA, UK
| | - N. A. Sheikh
- Department of Mechanical Engineering, Muhammad Ali Jinnah University, Islamabad, Pakistan
| | - R. D. Wildman
- Department of Chemical and Environmental Engineering, University Park, Nottingham NG7 2RD, UK
| |
Collapse
|
4
|
Sheikh NA, Wesley JD, Chadwick E, Perdue N, dela Rosa CP, Frohlich MW, Stewart FP, Urdal DL. Characterization of antigen-specific T-cell activation and cytokine expression induced by sipuleucel-T. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.7_suppl.155] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
155 Background: Sipuleucel-T (Provenge) is an autologous cellular immunotherapy designed to stimulate an immune response in men diagnosed with asymptomatic or minimally symptomatic metastatic castrate resistant prostate cancer. This study examined the role of GM-CSF in T cell activation and cytokine production in sipuleucel-T from men enrolled in phase III clinical trials (D9902B – IMPACT and P07-2 - PROACT). Methods: Sipuleucel-T is manufactured from peripheral blood mononuclear cells (PBMCs) isolated every two weeks by leukapheresis. PBMCs are cultured with PA2024, a recombinant human antigen consisting of prostatic acid phosphatase (PAP) and granulocyte macrophage-colony stimulating factor (GM-CSF), for two days and cultured cells are then infused into patients. After each leukapheresis, a proportion of the PMBCs were cultured ex vivo for two days with GM-CSF (sargromostim). The GM-CSF cultures were compared to sipuleucel-T for their T cell activation profiles, cytokine production, and upregulation of CD54 and CD86 using flow cytometry and MesoScale Discovery technologies. Results: Sipuleucel-T had increased APC activation-associated cytokines (IL-1a, IL-10, IL-12p70, IFNg and TNFa) and T cell activation- associated cytokines (IL-2, IL-4, IL-5, IL-6, IL-10, IL-13, IFNg and TNFa) with each treatment. In contrast, GM-CSF-cultured cells had lower levels of these cytokines. Both PA2024- and GM-CSF-cultured cells had upregulated CD54 and CD86. T cell (CD4+ and CD8+) activation-markers were increased upon PA2024 restimulation, as measured by CD134 (OX40), CD137 (4-1BB), CD278 (ICOS), and CD279 (PD-1) expression. Cells from PA2024-cultures, but not GM-CSF-cultures, displayed a generalized pattern of enhanced expression of the T cell activation markers at the second infusion compared to the first and third. Conclusions: These data indicate that T cell activation and enhanced cytokine expression are a consequence of priming after the first infusion. These effects are not driven by GM-CSF, as T cell activation and enhanced cytokine production were only observed in PA2024 cultures. [Table: see text]
Collapse
|
5
|
Stewart FP, dela Rosa CP, Sheikh NA, McNeel DG, Frohlich MW, Urdal DL, Provost NM. Correlation between product parameters and overall survival in three trials of sipuleucel-T, an autologous active cellular immunotherapy for the treatment of prostate cancer. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.4552] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
6
|
Abstract
There is no single universally accepted hallmark of antigen presenting cell (APC) activation. Instead a variety of methods are used to identify APCs and assess their activation state. These activation measures include phenotypic methods [e.g., assessing the increased expression of surface markers such as major histocompatability (MHC) class II] and functional assays (e.g., evaluating the enhanced ability to take up and process antigen, or stimulate naïve T cells). Sipuleucel-T is an investigational autologous active cellular immunotherapy product designed to stimulate a T cell immune response against human prostatic acid phosphatase (PAP), an antigen highly expressed in prostate tissue. Sipuleucel-T consists of peripheral blood mononuclear cells (PBMCs), including activated APCs displaying epitopes of PAP. In order to develop a robust reproducible potency assay that is not hampered by MHC restriction we have developed a method to simply assess the biological activation of antigen presenting cells (APCs). In the course of sipuleucel-T characterization, we analyzed various phenotypic and functional parameters to define the activation state of APCs obtained from peripheral blood. Flow cytometric assays revealed that CD54+ cells are responsible for antigen uptake, and that expression of CD54 predominantly localizes to APCs. Costimulation, as measured by an allogeneic mixed lymphocytic reaction (alloMLR) assay, showed that activity was restricted to the CD54+ cell population. Similarly, CD54+ cells harbor all of the PAP-specific antigen presentation activity, as assayed using a PAP-specific HLA-DRbeta1-restricted T cell hybridoma. Finally we show that CD54 expression is substantially and consistently upregulated on APCs during culture with a GM-CSF fusion protein, and that this upregulation activity can be quantified. Thus these data support the use of CD54 upregulation as a surrogate for assessing human APC activation and validates its utility as a potency measure of sipuleucel-T.
Collapse
Affiliation(s)
- N A Sheikh
- Dendreon Corporation, 3005 1st Avenue, Seattle, WA 98121, USA.
| | | |
Collapse
|
7
|
Abstract
Soluble or sub-unit protein vaccines alone are incapable of generating antigen-specific cellular immune responses. This failure can be attributed to the manner in which the immune system processes antigen; endogenous antigens are cycled through the MHC class I pathway to stimulate CD8+ restricted responses and exogenous antigens are processed through the MHC class II pathway to generate humoral immunity. Traditionally sub-unit vaccines have been formulated with adjuvants to enhance immunogenicity, however in the last decade a number of adjuvants have been developed that effectively stimulate the generation of both humoral and cellular immune responses, although the manner in which they exert their effects has not been investigated. Here we describe Tomatine, a glycoalkaloid based adjuvant, capable of stimulating potent antigen-specific humoral and cellular immune responses that contribute to protection against malaria, Francisella tularensis and regression of experimental tumors. Using in vivo models we investigated the manner in which cellular immune responses were generated by Tomatine. We established that Tomatine did not require either lymph node or splenic macrophages to generate cytotoxic T lymphocytes (CTL) and delivered soluble protein into a pathway not dependant on the machinery of the classical MHC class I pathway. We also observed that at the molecular level Tomatine required both CD80 and CD86 costimulation to engender antigen-specific cellular immunity.
Collapse
Affiliation(s)
- W J W Morrow
- Department of Pathobiology, Washington National Primate Research Center, University of Washington, 3000 Western Avenue, Seattle, WA 98004, USA.
| | | | | |
Collapse
|
8
|
Heal KG, Sheikh NA, Hollingdale MR, Morrow WJ, Taylor-Robinson AW. Potentiation by a novel alkaloid glycoside adjuvant of a protective cytotoxic T cell immune response specific for a preerythrocytic malaria vaccine candidate antigen. Vaccine 2001; 19:4153-61. [PMID: 11457540 DOI: 10.1016/s0264-410x(01)00166-9] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
We have recently demonstrated that the novel glycoalkaloid tomatine, derived from leaves of the wild tomato Lycopersicon pimpinellifolium, can act as a powerful adjuvant for the elicitation of antigen-specific CD8+ T cell responses. Here, we have extended our previous investigation with the model antigen ovalbumin to an established malaria infection system in mice and evaluated the cellular immune response to a major preerythrocytic stage malaria vaccine candidate antigen when administered with tomatine. The defined MHC H-2kd class I-binding 9-mer peptide (amino acids 252-260) from Plasmodium berghei circumsporozoite (CS) protein was prepared with tomatine to form a molecular aggregate formulation and this used to immunise BALB/c (H-2kd) mice. Antigen-specific IFN-gamma secretion and cytotoxic T lymphocyte activity in vitro were both significantly enhanced compared to responses detected from similarly stimulated splenocytes from naive and tomatine-saline-immunised control mice. Moreover, when challenged with P. berghei sporozoites, mice immunised with the CS 9-mer-tomatine preparation had a significantly delayed onset of erythrocytic infection compared to controls. The data presented validate the use of tomatine to potentiate a cellular immune response to antigenic stimulus by testing in an important biologically relevant system. Specifically, the processing of the P. berghei CS 9-mer as an exogenous antigen and its presentation via MHC class I molecules to CD8+ T cells led to an immune response that is an in vitro correlate of protection against preerythrocytic malaria. This was confirmed by the protective capacity of the 9-mer-tomatine combination upon in vivo immunisation. These findings merit further work to optimise the use of tomatine as an adjuvant in malaria vaccine development.
Collapse
Affiliation(s)
- K G Heal
- School of Biology, University of Leeds, Clarendon Way, LS2 9JT, Leeds, UK
| | | | | | | | | |
Collapse
|
9
|
Choudhury HR, Sheikh NA, Bancroft GJ, Katz DR, De Souza JB. Early nonspecific immune responses and immunity to blood-stage nonlethal Plasmodium yoelii malaria. Infect Immun 2000; 68:6127-32. [PMID: 11035715 PMCID: PMC97689 DOI: 10.1128/iai.68.11.6127-6132.2000] [Citation(s) in RCA: 57] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
The early role of natural killer cells and gamma delta T cells in the development of protective immunity to the blood stage of nonlethal Plasmodium yoelii infection was studied. Splenic cytokine levels were measured 24 h after infection of natural killer cell-depleted immunodeficient and littermate mice or transiently T-cell-depleted normal mice. Splenic gamma interferon levels were significantly increased above background in immunodeficient and littermate mice 24 h after infection. Depletion of natural killer cells resulted in markedly depressed gamma interferon levels and poor control of parasitemia, particularly in severe combined immunodeficient mice. In the littermates, gamma interferon levels were partially reduced, but parasitemias were resolved normally. However, in athymic mice, natural killer cell depletion had no effect on gamma interferon production. Levels of tumor necrosis factor alpha were increased in all animals 24 h after infection, and responses were not affected by natural killer cell depletion. However, in T-cell-depleted animals, both gamma interferon and tumor necrosis factor alpha levels were decreased 24 h after infection, and depleted mice were unable to control their parasitemia. These results suggest that the early production of both cytokines is important in the early control of parasitemia and that both natural killer and gamma delta T cells contribute equally towards their production. The data also suggest that the subsequent resolution of infection requires early production of gamma interferon, which might act by switching on the appropriate T-helper-cell subsets and other essential parasitotoxic effector mechanisms.
Collapse
Affiliation(s)
- H R Choudhury
- Department of Immunology, Royal Free and University College London Medical School, Windeyer Institute of Medical Science, London W1P 6DB, United Kingdom
| | | | | | | | | |
Collapse
|
10
|
Sheikh NA, al-Shamisi M, Morrow WJ. Delivery systems for molecular vaccination. Curr Opin Mol Ther 2000; 2:37-54. [PMID: 11249651] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]
Abstract
Vaccination is one of the medical success stories of the 20th century, however, there are many diseases for which no prophylactic regimes are available. A major hindrance that has prevented the development of effective mass immunization programs is the inability to induce an appropriate, protective, immune response. For example, for vaccines against intracellular pathogens there is a requirement for cell-mediated immunity as characterized by cytolytic T-lymphocyte activity. However, such a response can be extremely difficult to elicit, especially those employing recombinant, soluble protein subunits. This deficiency is due to the inability of these antigens to access the machinery of the appropriate antigen-processing pathway. Following an improved understanding of the mechanisms underlying such processing, as well as the realization that delivery systems can affect, quantitatively and qualitatively, the resulting immune response, the last decade has witnessed an intense research effort in this field. In this article we will review the major developments in the area of antigen delivery as related to vaccination.
Collapse
Affiliation(s)
- N A Sheikh
- Department of Pharmaceutics & Washington Regional Primate Research Center, University of Washington, Seattle, WA 98121, USA
| | | | | |
Collapse
|
11
|
Rajananthanan P, Attard GS, Sheikh NA, Morrow WJ. Novel aggregate structure adjuvants modulate lymphocyte proliferation and Th1 and Th2 cytokine profiles in ovalbumin immunized mice. Vaccine 1999; 18:140-52. [PMID: 10501244 DOI: 10.1016/s0264-410x(99)00213-3] [Citation(s) in RCA: 43] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Cytokines are important mediators of effector lymphoid cell function during an immune response. The principal cytokine producers are the T helper (Th) cells and macrophages. Vaccine strategies need to take into account the balance of Th (Th1/Th2) cytokines they induce. Adjuvants are compounds that, when combined with an antigen, potentiate an immune response in an immunized species. The use of adjuvants has been shown to activate differentially Th1 and Th2 subsets. In this study we describe the immunopotentiating properties of three novel molecular aggregate formulations based on tomatine (RAM1), a glycosylamide lipid (RAM2) and a fifth generation dendrimeric polymer (RAM3) respectively. These formulations were evaluated for their ability to augment Th1 or Th2 cytokine responses when administered with a soluble protein antigen. Of the three formulations, RAM1 was found to induce predominantly Th1 cytokines; the levels of which were substantially higher than those induced by reference control adjuvants. It was also found that at a late post-vaccinated period, RAM1 can stimulate Th2 responses. In contrast, RAM2 and RAM3 induced cytokine profiles typically associated with Th2 responses.
Collapse
Affiliation(s)
- P Rajananthanan
- St. Bartholomew's and The Royal London School of Medicine and Dentistry, Department of Immunology, UK
| | | | | | | |
Collapse
|
12
|
Sheikh NA, Rajananthanan P, Attard GS, Morrow WJ. Generation of antigen specific CD8+ cytotoxic T cells following immunization with soluble protein formulated with novel glycoside adjuvants. Vaccine 1999; 17:2974-82. [PMID: 10462232 DOI: 10.1016/s0264-410x(99)00173-5] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Presentation of peptide on MHC class I molecules is essential to elicit cytolytic T cell (CTL) activity. Such peptides are a result of the cytosolic, or class I, antigen processing pathway. Due to the segregation of the class I and the exogenous processing pathway, soluble protein cannot enter the class I pathway and is thus incapable of inducing CTL. However careful formulation with adjuvants can overcome this obstacle. In this study we evaluated the capacity of two novel amphiphilic adjuvants, better termed delivery vehicles, to elicit CTL activity in a C57Bl/6 murine model with ovalbumin (OVA) as an antigen. Incomplete Freund's adjuvant and aluminium hydroxide (Alhydrogel) were used as reference adjuvants. In addition the oil-in-water emulsion Provax was used throughout as a positive control adjuvant. Both amphiphile preparations were capable of eliciting potent CTL activity after administration of one immunizing dose of ovalbumin. CTL were CD8+ restricted as assessed by in vitro depletion of CD8+ and CD4+ T cells. CTL activity was also MHC-restricted as well as specific for the H-2Kb OVA motif SIINFEKL.
Collapse
Affiliation(s)
- N A Sheikh
- Department of Immunology, St. Bartholomew's and The Royal London School of Medicine and Dentistry, UK
| | | | | | | |
Collapse
|
13
|
Abstract
Adjuvants are compounds that, when combined with an antigen, potentiate an immune response in an immunized species. There are numerous pathogens for which there are no protective vaccines and since alum is the only adjuvant licensed for use in humans, there is a clear need for more effective adjuvant preparations. In this study we describe the immunopotentiating properties of three novel molecular aggregate formulations based on tomatine (RAM1), a glycosylamide lipid (RAM2) and a fifth generation dendrimeric polymer (RAM3) respectively. These formulations were evaluated for their ability to augment antigen-specific antibody responses when administered with a soluble protein antigen. All three adjuvants were shown to be nontoxic to mice and elicited antigen-specific antibody responses. Of the three formulations, RAM1 was found to induce the highest titers of antibody; these were substantially higher than those induced by reference control adjuvants. RAM1 elicited antibodies of the IgG1 and IgG2a subclasses indicating, indirectly, that this adjuvant can stimulate Th2 and Th1 type immunity.
Collapse
Affiliation(s)
- P Rajananthanan
- Department of Immunology, St. Bartholomew's and The Royal London School of Medicine and Dentistry, UK
| | | | | | | |
Collapse
|
14
|
Zaki M, Zaman V, Sheikh NA. Resistance of blastocystis hominis cysts to chlorine. J PAK MED ASSOC 1996; 46:178-9. [PMID: 8936976] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Affiliation(s)
- M Zaki
- Department of Microbiology, Aga Khan University, Karachi
| | | | | |
Collapse
|
15
|
Caro HN, Sheikh NA, Taverne J, Playfair JH, Rademacher TW. Structural similarities among malaria toxins insulin second messengers, and bacterial endotoxin. Infect Immun 1996; 64:3438-41. [PMID: 8757890 PMCID: PMC174245 DOI: 10.1128/iai.64.8.3438-3441.1996] [Citation(s) in RCA: 24] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023] Open
Abstract
Malaria toxin causes hypoglycemia and induction of tumor necrosis factor. Extracts of parasitized erythrocytes which were coeluted and copurified with one of the two subtypes of mammalian insulin-mimetic inositolphosphoglycans similarly induced fibroblast proliferation in the absence of serum. In addition, induction of tumor necrosis factor in macrophages by malaria toxin and by lipopolysaccharide from Escherichia coli was enhanced by pretreatment of these toxins with alpha-galactosidase. Thus, parasitized erythrocytes contain both soluble inositolphosphoglycan-like insulin second messengers and endotoxin-like lipidic molecules.
Collapse
Affiliation(s)
- H N Caro
- Molecular Medicine Unit, Department of Molecular Pathology, University College London Medical School, United Kingdom
| | | | | | | | | |
Collapse
|
16
|
Sheikh NA, Caro HN, Taverne J, Playfair JH, Rademacher TW. Malaria: a tumour necrosis factor inhibitor from parasitized erythrocytes. Immunology 1996; 87:461-6. [PMID: 8778034 PMCID: PMC1384117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023] Open
Abstract
The excessive production of tumour necrosis factor (TNF) is associated with the pathology of blood-stage malaria and phosphatidylinositol-containing phospholipid antigens from parasitized erythrocytes stimulate its secretion by macrophages, thus acting as toxins. This brief report describes some properties of an inhibitor present in lysates from erythrocytes infected with malarial parasites that blocked the detection of recombinant TNF in an enzyme-linked immunosorbent assay and diminished or abolished the cytotoxicity of TNF. It was not found in control lysates of normal erythrocytes. Its addition to macrophage cultures stimulated by toxic malarial preparations or by bacterial lipopolysaccharide also blocked the detection of TNF. These findings may explain the contradictory results obtained from different assays for TNF, and emphasize the need for caution when interpreting the results of a single assay system. If released when parasitized erythrocytes rupture in vivo, the inhibitor could help protect both parasite and host from the damaging effects of TNF.
Collapse
Affiliation(s)
- N A Sheikh
- Department of Immunology, University College London Medical School, UK
| | | | | | | | | |
Collapse
|